MedPath

Creatine Supplementation and Diabetes

Not Applicable
Completed
Conditions
Diabetes
Renal Function
Registration Number
NCT00992043
Lead Sponsor
University of Sao Paulo
Brief Summary

Creatine supplementation is capable of improving glucose tolerance in healthy subjects. The researchers aim to investigate whether this supplement can affect metabolic control in diabetic patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • males and females type 2 diabetic patients
  • glycated hemoglobin between > 9%
  • non insulin users
  • physically inactive
  • only metformin and/or sulfonylurea users
  • BMI > 30 kg/m2
  • age of years > 50 y
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
glycated hemoglobinthree months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

General Hospital - School of Medicine - University of Sao Paulo

🇧🇷

Sao Paulo, Brazil

General Hospital - School of Medicine - University of Sao Paulo
🇧🇷Sao Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.